7/31/2019 CP Intestinal Obstruction Chap7
1/57
Chapter VII
MEDICAL AND NURSING MANAGEMENT
A. Ideal Diagnostic Tests
i. Abdominal CT scan - combines special x-ray equipment with
sophisticated computers to produce multiple images or pictures of
the inside of the body. These cross-sectional images of the area
being studied can then be examined on a computer monitor,
printed or transferred to a CD.
ii. Abdominal X-Ray - An abdominal X-ray is a picture of structures
and organs in the belly (abdomen). This includes the stomach,
liver, spleen, large and small intestines, and the diaphragm, which
is the muscle that separates the chest and belly areas. Often two X-
rays will be taken from different positions. An abdominal X-ray may
be one of the first tests done to find a cause of belly pain, swelling,
nausea, or vomiting.
iii. Abdominal Ultrasonography - An ideal clinical tool for determining
the source of abdominal pain. It can simplify the differential
diagnosis of abdominal pain, especially when pain and tenderness
are present over the site of disease.
http://www.webmd.com/hw-popup/x-rayhttp://www.webmd.com/hw-popup/abdominal-organshttp://www.webmd.com/hw-popup/x-rayhttp://www.webmd.com/hw-popup/abdominal-organs7/31/2019 CP Intestinal Obstruction Chap7
2/57
iv. Barium Enema - X-ray examination of the large intestine (colon
and rectum). The test is used to help diagnose diseases and other
problems that affect the large intestine. To make the intestine
visible on an X-ray picture, the colon is filled with a contrast
material containing barium. This is done by pouring the contrast
material through a tube inserted into the anus.
v. Laboratory studies (e.g., electrolyte studies and a complete blood
cell count) reveal a picture of dehydration, loss of plasma volume,
and possible infection.
B. Ideal Medical Management
Decompression of the bowel through a nasogastric or small bowel
tube is successful in most cases. When the bowel is completely
obstructed, the possibility of strangulation warrants surgical intervention.
Before surgery, intravenous therapy is necessary to replace the
depleted water, sodium, chloride, and potassium.
The surgical treatment of intestinal obstruction depends largely on
the cause of the obstruction. In the most common causes of obstruction,
such as hernia and adhesions, the surgical procedure involves repairing
the hernia or dividing the adhesion to which the intestine is attached. In
52
http://www.webmd.com/hw-popup/x-rayhttp://www.webmd.com/hw-popup/large-intestinehttp://www.webmd.com/hw-popup/contrast-materialhttp://www.webmd.com/hw-popup/contrast-materialhttp://www.webmd.com/hw-popup/x-rayhttp://www.webmd.com/hw-popup/large-intestinehttp://www.webmd.com/hw-popup/contrast-materialhttp://www.webmd.com/hw-popup/contrast-material7/31/2019 CP Intestinal Obstruction Chap7
3/57
some instances, the portion of affected bowel may be removed and an
anastomosis performed. The complexity of the surgical procedure for
intestinal obstruction depends on the duration of the obstruction and the
condition of the intestine.
A colonoscopy may be performed to untwist and decompress the
bowel. A cecostomy, in which a surgical opening is made into the cecum,
may be performed for patients who are poor surgical risks and urgently
need relief from the obstruction. The procedure provides an outlet for
releasing gas and a small amount of drainage.
A rectal tube may be used to decompress an area that is lower in
the bowel. The usual treatment, however, is surgical resection to remove
the obstructing lesion.
A temporary or permanent colostomy may be necessary. An
ileoanal anastomosis may be performed if it is necessary to remove the
entire large colon.
C. Ideal Nursing Management
Nursing management of the nonsurgical patient with a small bowel
obstruction includes maintaining the function of the nasogastric tube,
assessing and measuring the nasogastric output, assessing for fluid and
electrolyte imbalance, monitoring nutritional status, and assessing
improvement (eg, return of normal bowel sounds, decreased abdominal
53
7/31/2019 CP Intestinal Obstruction Chap7
4/57
distention, subjective improvement in abdominal pain and tenderness,
passage of flatus or stool). The nurse reports discrepancies in intake and
output, worsening of pain or abdominal distention, and increased
nasogastric output. If the patients condition does not improve, the nurse
prepares him or her for surgery. The exact nature of the surgery depends
on the cause of the obstruction. Nursing care of the patient after surgical
repair of a small bowel obstruction is similar to that for other abdominal
surgeries
D. Actual Diagnostic Tests
Fluid Serum
December 8, 2010
Electrolytes exist in the blood as acids, bases, and salts (such
as sodium, calcium,potassium, chloride, magnesium, and bicarbonate).
They control such things as cardiac function and muscle contraction and
are routinely measured by laboratory studies of the serum.
Fluid Serum is the cell-free fluid of the bloodstream. It appears in a
test tube after the blood clots and is often used in expressions relating to
the levels of certain compounds in the blood stream.
54
http://www.digitalnaturopath.com/treat/T134865.html#G750http://www.digitalnaturopath.com/treat/T134865.html#G539http://www.digitalnaturopath.com/treat/T134865.html#G539http://www.digitalnaturopath.com/treat/T134865.html#G722http://www.digitalnaturopath.com/treat/T134865.html#G650http://www.digitalnaturopath.com/treat/T134865.html#G118http://www.digitalnaturopath.com/treat/T134865.html#G745http://www.digitalnaturopath.com/treat/T134865.html#G750http://www.digitalnaturopath.com/treat/T134865.html#G539http://www.digitalnaturopath.com/treat/T134865.html#G722http://www.digitalnaturopath.com/treat/T134865.html#G650http://www.digitalnaturopath.com/treat/T134865.html#G118http://www.digitalnaturopath.com/treat/T134865.html#G7457/31/2019 CP Intestinal Obstruction Chap7
5/57
A Blood chemistry test is a procedure to examine the general
health of a patient especially to assess the functioning of certain organs.
Test Result Reference value Interpretation
Creatinine 0.8 mg/dl 0.7-1.2 Normal
Sodium 137 mmol/L 137-145 Normal
Potassium 3.4 mmol/L 3.5-5.0 Low
Amylase 37 u/L 30-110 Normal
Interpretation:
The table shows that Potassium is slightly decreased. This
decrease in potassium may be due to patients vomiting, deficient
potassium intake, or dehydration.
Nursing Responsibilities:
define and explain the test
state the specific purpose of the test
explain the procedure
discuss test preparation, procedure, and posttest care
some blood chemistry tests will have specific requirements such as
dietary restrictions or medication restrictions.
55
7/31/2019 CP Intestinal Obstruction Chap7
6/57
Complete Blood Count
December 8, 2010
The complete blood count (CBC) is one of the most commonly
ordered blood tests. The complete blood count is the calculation of the
cellular (formed elements) of blood. These calculations are generally
determined by special machines that analyze the different components of
blood in less than a minute.
This test may be a part of a routine check-up or screening, or as a
follow-up test to monitor certain treatments. It can also be done as a part
of an evaluation based on a patient's symptoms.
Test Results ReferenceValue
Interpretation
WBC 12.1 5-10 x 10^9/L High
Segmenters 0.76 0.55-0.65 High
Lymphocyte 0.15 0.25-0.35 Low
Monocyte 0.08 0.03-0.06 High
Eosinophil 0.01 0.02-0.04 Low
Hemoglobin 96 140-170 9/L Low
Hematocrit 0.29 0.40-0.50
volume
Low
Platelet 291 150-350x10^9/L Normal
56
7/31/2019 CP Intestinal Obstruction Chap7
7/57
Interpretation:
CBC is a combination report of a series of test of the peripheral
blood. White blood cells (leukocytes) are bodys defense against
infective organisms and foreign substances. The table shows that there is
elevated number of WBC which indicates that there is possible infection or
immunosuppression happening inside.
Segmenters are above the normal range which indicates infection.
Low lymphocyte, Eosinophil and Monocyte count indicates that
the body's resistance to fight infection has been substantially lost and one
may become more susceptible to certain types of infection, namely cancer
and tumor. As lymphocyte cells make up fifteen to forty percent of the total
white blood cells that circulate in the bloodstream, a low count can cause
damage to organs.
Hemoglobin is the oxygen carrying protein within the RBCs. The
table shows that there is decreased hemoglobin concentration in the
blood, which indicates that there is less oxygen being transported
throughout the body, because of the less oxygen being transported. With
this, the patient is likely experiencing difficulty of breathing that leads
patient to have impaired gas exchange.
Hematocrit is the percentage of RBC mass to original blood
volume. The table shows that hematocrit volume is decreased which
57
http://www.buzzle.com/articles/cancer/http://www.buzzle.com/articles/cancer/7/31/2019 CP Intestinal Obstruction Chap7
8/57
indicates that there is over expansion of extra cellular fluid volume, since
the patient has a decreased RBC she also have a decreased hematocrit
level.
Nursing Responsibilities:
Explain that the tests are done to detect any hematologic disorders
as well as infection and inflammation.
Tell the patient that a blood sample will be taken and that she may
feel slight discomfort from the tourniquet and needle puncture.
Use gloves when collecting and handling all specimens.
Transport the specimen to the laboratory as soon as possible after
the collection.
Do not allow the blood sample to clot, of the results will be invalid.
Place the specimen in a biohazard bag.
Abdomen Supine and upright
December 8, 2010
Abdominal x-rays may be performed to diagnose causes of
abdominal pain, such as masses, perforations, or obstruction. Abdominal
x-rays may be performed prior to other procedures that evaluate the
58
7/31/2019 CP Intestinal Obstruction Chap7
9/57
gastrointestinal (GI) tract or urinary tract, such as an abdominal CT scan
and renal procedures.
Result:
Lung bases are clear. Free subphrenic air is noted. There are gas
containing loops of small and large bowel in all quadrants with no definite
pattern. An ovoid soft tissue density is seen in the right lower quadrant
area overlying pattern of the right superior iliac crest. This is seen in the
supine view only and may be in the soft tissues. Reacted gas is present.
There are advance degenerative changes in lumbar spine characterized
by osteophytes/ spurs formation. Asymmetrical narrowing of L4-L5
intervertebral joint space, left is seen with linear lucencies within. Mild
levoseoliosis is noted.
Impression:
Essentially (-) study of the abdomen save for degenerative changed
of the lumbar spine.
Abdomen Supine and upright
December 9, 2010
Re-examination no longer shows the ovoid soft tissue density in the
right lower quadrant area or seen in the abdominal supine view. Gas
containing loops of predominantly small bowel segments are still seen in
59
7/31/2019 CP Intestinal Obstruction Chap7
10/57
all quadrants with no definite pattern. Rectal gas is present. Pro-
peritoneal flank stripes are intact, abdomen are not displaced laterally.
Nursing Management:
Remove any clothing, jewelry, or other objects that might interfere
with the procedure.
Given a gown to wear.
Position in a manner that carefully places the part of the abdomen
that is to be observed. The patient may be asked to stand erect, to
lie flat on a table, or to lie on the side on a table, depending on the
x-ray view the physician has requested.
Body parts not being imaged may be covered with a lead apron
(shield) to avoid exposure to the x-rays.
Once positioned, ask the patient to hold still for a few moments
while the x-ray exposure is made. Also, ask the patient to hold
his/her breath at various times during the procedure.
It is extremely important to remain completely still while the
exposure is made, as any movement may distort the image and
even require another x-ray to be done to obtain a clear image of the
body part in question.
The x-ray beam is then focused on the area to be photographed.
60
7/31/2019 CP Intestinal Obstruction Chap7
11/57
Urinalysis
December 9, 2010
Routine urinalysis is performed for general health screening to
detect renal and metabolic diseases; to diagnose diseases or disorders of
the kidneys or urinary tract. In addition, it is performed to help diagnose
specific disorders such as endocrine diseases.
Physical properties:
Color Reaction Transparency Specific gravity
Light yellow 6.0 Clear 1.003
Chemical reaction:
Sugar Albumin
Negative Negative
Microscopic examination:
Pus cell RBC
0.1/ HPF 0.1/ HPF
Interpretation:
The physical and chemical properties of the patients urine show
normal results. Normally, blood must be absent in the urine. Presence of
blood may indicate acute kidney infections, chronic infections, and stone
formation in the kidneys.61
7/31/2019 CP Intestinal Obstruction Chap7
12/57
Nursing Responsibilities:
Explain how to collect a clean catch specimen of at least 15 mL.
Explain that there is no food or fluids restriction.
Obtain a first voided morning specimen if possible.
Medications may be restricted for it may affect laboratory results.
Fecalysis
December 9, 2010
It refers to a series of laboratory tests done on fecal samples to
analyze the condition of a person's digestive tract in general. Among other
things, a fecalysis is performed to check for the presence of any reducing
substances such as white blood cells (WBCs), sugars, or bile and signs of
poor absorption as well as screen for colon cancer.
Color Chemical and occult
blood
Result
Black Positive No intestinal parasite
62
7/31/2019 CP Intestinal Obstruction Chap7
13/57
seen
Interpretation:
Black stool may be a result of possible internal bleeding,
particularly somewhere in the digestive tract.
Nursing Responsibilities:
Discourage patient from taking aspirin, alcohol, vitamin C,
ibuprofen, and certain types of food if fecal sample will be checked
for any sign of blood.
The patient must urinate first to prevent any urine from mixing with
feces.
The patient must wear gloves when it's time to handle stool and
transfer it to a safer container. This will prevent any possibilities of
being contaminated or infected by bacteria found within the stool.
Solid and liquid fecal samples are both acceptable as long as they
do not have urine or other foreign substances like soap, water, and
toilet paper mixed in them.
If the patient is suffering from diarrhea, placing a plastic wrap and
securing it under the toilet seat could facilitate the collection
process.
63
7/31/2019 CP Intestinal Obstruction Chap7
14/57
Collected samples must be brought to the doctor's office or
laboratory as soon as possible. Delays could compromise the
quality of the sample.
Volume or amount is also important so the patient must be sure he
has collected an adequate amount of stool.
Potassium Test
December 10, 2010
This test measures the amount of potassium in the blood.
Potassium (K+) helps nerves and muscles communicate. It also helps
move nutrients into cells and waste products out of cells.
Test Result Reference value Interpretation
Potassium 4.1 3.6-5.0 mmol/L Normal
Interpretation:
The potassium level of the patient is normal.
Ultrasound in the Whole Abdomen
December 10, 2010
64
7/31/2019 CP Intestinal Obstruction Chap7
15/57
It is an ideal clinical tool for determining the source of abdominal
pain. It can simplify the differential diagnosis of abdominal pain, especially
when pain and tenderness are present over the site of disease.
Result:
Liver is normal in size and contour. It shows normal homogenous
echo pattern. No mass lesion is noted. Intrahepatic bile ducts and CBD
are not dilated. Hepatic vessels are unremarkable. Gallbladder is
physiologically distended. It shows normal wall thickness. No internal
echoes are noted. No pevicholecystic fluid collection is seen.
Pancreas and spleen are normal. Right kidney measures 9.6 x 4.2
cm with cortical thickness of 1.2 cm. Left kidney measures 9.5 x 4.0 cm
with cortical thickness of 1.5 cm. Both are normal in size showing
homogenous corticomedullary parenchymal echogenecity. No echogenic
focus or mass lesion is noted. There is no separation of the central echo
complexes. Proximal uterus is not dilated. Uterus is atrophic and is
compatible with the age of the patient. No abnormal masses are seen in
both advexac.
Moderately dilated, fecal-filled segment of large bowel are noted in
both paracolic gutters, iliac regions and pelvis. No evident mass lesion is
appreciated.
65
7/31/2019 CP Intestinal Obstruction Chap7
16/57
Impression:
Considers ileus; Partial obstruction
Fecal stasis
Nursing Responsibilities:
Before procedure, instruct patient to be on NPO 8-12 hrs since air
or gas can reduce quality of image
Assess abdominal distention because it may affect quality ofimage
During procedure, keep the patient in a supine position
E. Actual Medical Management
Date Ordered Doctors order Rationale66
7/31/2019 CP Intestinal Obstruction Chap7
17/57
December 8,
2010 (8:39 PM)
c/c: abdominal
pain
T-370C
PR-92bpm
RR-24cpm
BP-
122/76mmHg
O2-95
HG-145
Please admit room of
choice under the service
of Dr. Albano
NPO
CBC, serum Amylase
blood type
U/A
Na, K, Creatinine
Req. X-ray of abdomen
flat
For admission and to
provide quality care.
In preparation for
diagnostic tests.
To diagnose a
disease and evaluatethe stages of the
particular disease.
General health
screening to detect
renal and metabolic
disease.
To examine the
general health of a
patient especially to
assess the
functioning of certain
organs.
To view the
obstruction in the
67
7/31/2019 CP Intestinal Obstruction Chap7
18/57
PLR 1 L x 12o
TPR monitor and record
Decrease IVF to 60cc/hr
Fecalysis and stool for
occult
Prosec IV now
intestine.
To replenish fluid loss
and electrolyte
imbalance.
For baseline data.
To check for the
presence of blood.
For antacids and
antiulcer function.
December 8,
2010 (10:40
PM)
Incorporate 30 mEq KCl
to present IVF
To provide a direct
replacement of
potassium in the
body.
December 9,
2010
Soft abdomen
(-) flatus
Soft diet
kalium durule TID x 6
doses
D5NM x 16o
To prevent further
obstruction.
To provide a direct
replacement of
potassium in the
body.
To replenish fluid loss
and electrolyte
68
7/31/2019 CP Intestinal Obstruction Chap7
19/57
Nexium p.o OD
Motilium tab TID
imbalance.
To reduce gastric
acid secretion.
To increase the
movements or
contractions of the
stomach and bowel.
It is also used to treat
nausea and vomiting.
December 10,
2010
Senokot Forte 2 tabs now
For Serum test (1:45)
Ultrasound of whole
abdomen
Cleansing enema
To stimulate
peristalsis and
increase intestinal
motility.
To examine the
general health of a
patient especially to
assess the
functioning of certain
organs.
For determining the
source of abdominal
pain.
To alleviate
symptoms of poor
69
7/31/2019 CP Intestinal Obstruction Chap7
20/57
Colonoscopy tomorrow
12 noon
Dulcolax 2 tabs tonight
digestive health.
To examine colon
internally.
It stimulates bowel
movements.
December 11,
2010
Tympanic
abdomen
Senokot Forte 2 tabs BID
x 3 doses
Soft diet
D5LR 1 L x 16o
D5LR 1 L x 16o (10:35)
To stimulate
peristalsis and
increase intestinal
motility.
To prevent further
obstruction.
For maintenance of
nutritional balance.
December 12,
2010
Partial
obstruction
Discussed with
patient/ relative
(+) BM
Lactulose 30 cc To increase water
content in colon and
enhances peristalsis
and for the
breakdown of
products in colon that
lead to acidification of
colonic contents,
softening of feces,
and decreased
ammonia absorption
from colon to
70
7/31/2019 CP Intestinal Obstruction Chap7
21/57
D5NM 1 L x 16o
Continue soft diet
systemic circulation.
December 13,
2010
(-) BM
11:25 AM
NPO
Vomit (3x)
(-) BM
(-) flatus x 2
days
(+) vomiting
NPO
Refer to Dr. Mercado for
co- management
D5NM 1 L x 12o
Give Metoclopramide 1
amp IVTT now
Assessment: For surgical
management - Bowel
obstruction
For emergency exlap
5PM today once cleared
AP Homez for anesthesia
For Na+ K+- refer to Dr. A
Rosete for CP clearance
No absolute
contraindication for
To reduce nausea
and vomiting.
To treat large bowel
obstruction.
To know the real
cause of obstruction.
To assist during
surgery.
In preparation for
surgery.
71
7/31/2019 CP Intestinal Obstruction Chap7
22/57
(-) HPN, (-) DM
11:20 PM
surgery (ex-lap)
Re: acute abdomen-
intestinal obstruction
Nebulize with combivent
1 ampule before transport
to OR
Transderm 5mg patch to
Left Anterior Chest now
OD
Secure 2 u of FWB/
packed RBC for OR use
Transderm patch- defer if
BP 90 systolic
Post-op orders
To RR x 2o then back to
room if stable
O2 at 2-3 LPM
Flat on bed until fully
awake
VS q 15, q 10
NPO- NGT tip (opened)
attached to BTB
IVF right- KVO rate
BT #1 of packed RBC at
To assist respiration.
To replace blood
loss.
For respiration.
To promote
circulation.
For monitoring.
To replace blood
loss.
72
7/31/2019 CP Intestinal Obstruction Chap7
23/57
11:20 PM
11:55 PM
20-25 gtts/min. To follow
BT as packed RBC BT #2
IVF left- LR at 30
gtts/min.
TF D5LR 1 L x 8o
Sidedrip- NSS 500 cc +
voltaren 2 ampules at 20
cc/hr
post-op meds
1. cefuroxime 750 mg q8o
IVTT
2. metronidazole left IVF
500 mg q8o at AM
3. Omepron 8 AM OD 40
mg IVTT OD
4. Voltaren 20 cc/hr
5. Nebulize with
Combivent now then q8o
with volume/ volume
6. nalbuphine 5 mg q6o x
12 doses IVTT (6AM-12-
6-12AM)
Replace NGT loss q4o
(volume/ volume
replacement) To assist the patient
73
7/31/2019 CP Intestinal Obstruction Chap7
24/57
SPO2 95-96%
11:57 PM
December 14,
2010
10:45 AM
Patient
comfortable
Clear breath
sounds
O2 via face mask at 2-3
LPM RTC
Attach to pulse oximeter
at bedside
Specimen for pathologic
exam
Continue nebulization
every 8o
D/c O2 supplement
for enhanced airway.
For monitoring.
To assist her
respiration
Surgery
An exploratory laparotomy is done especially when a person
complains of abdominal pain. The operation allowed the surgeon to
examine the internal organs. Disease or damage can be uncovered. In
some cases, the problem can be corrected during the surgery.
A colostomy is when the colon is cut in half and the end leading to
the stomach is brought through the wall of the abdomen and attached
to the skin. The end of the colon that leads to the rectum is closed off
74
7/31/2019 CP Intestinal Obstruction Chap7
25/57
and becomes dormant. Usually a colostomy is performed for infection,
blockage, or in rare instances, severe trauma of the colon. This is not
an operation to be taken lightly. It is truly quite serious and demands
the close attention of both patient and doctor. A colostomy is often
performed so that an infection can be stopped and/or the affected colon
tissues can heal.
F. Actual Nursing Management
Assess and measure the nasogastric output
Assess fluid and electrolyte balance and administer IV as
prescribed
Monitor nutritional status
Assess improvement such as return of normal bowel sounds,
decreased abdominal distention, abdominal pain and
tenderness, passage of flatus or stool
Prepare patient for surgery which includes preoperative
teaching
After surgery, provide wound care and post-operative nursing
care
75
7/31/2019 CP Intestinal Obstruction Chap7
26/57
Place ice chips on the same day of surgery to ease the
patients thirst. By the next day, the patient may be allowed to
drink clear liquids.
Slowly add thicker fluids and then soft foods as the bowels
begin to work again.
Patient may eat normally within 2 days after the surgery.
The colostomy drains stool (feces) from the colon into the
colostomy bag. Most colostomy stool is softer and more liquid
than stool that is passed normally. The texture of stool
depends on the location of the segment of intestine used to
form the colostomy.
G.Actual Pharmacologic Management (Drug Study)
Drug # 1
Date Ordered: Dec. 09, 2010
Generic Name: esomeprazole magnesium
Brand Name: Nexium
Classification:Antiulcer drugs
Dosage: 40 mg 1 tab OD P.O
76
7/31/2019 CP Intestinal Obstruction Chap7
27/57
Mechanism of Action: Proton pump inhibitor that reduces gastric acid
secretion and decreases gastric acidity.
Indications:
Indicated to Gastroesophageal reflux disease (GERD)
Healing erosive esophagitis
Reduce the risk of gastric ulcers in patients receiving continuous
NSAID therapy.
Contraindications:
Contraindicated to patients hypersensitive to drug or components of
esoprazole or omeprazole.
Patients receiving continuous NSAID therapy who are at increased
risk for gastric ulcers include those age 60 and older or those with a
history of gastric ulcers.
Adverse Reactions:
CNS: headache
GI: dry mouth, diarrhea, abdominal pain, nausea, flatulence,
vomiting, constipation
Nursing Responsibilities:
Give drug at least 1 hour before meals.
Antacids can be used while taking drug, unless otherwise directed
by prescriber.
77
7/31/2019 CP Intestinal Obstruction Chap7
28/57
Monitor patient for rash or signs and symptoms of hypersensitivity
or worsening.
Monitor GI symptoms for improvement or worsening.
Instruct patient to take drug exactly as prescribed.
Health Teachings:
Tell patient to take drug at least 1 hour before a meal.
Advise patient that antacids can be used while taking drug unless
otherwise directed by prescriber.
Warn patient not to chew or crush drug pellets because this makes
the drug ineffective.
Tell patient to inform prescriber of worsening signs and symptoms
or pain.
Rationale: To reduce gastric acid secretion.
Drug # 2
Date Ordered: Dec. 09, 2010
Generic Name: potassium chloride
Brand Name: Kalium Durule
Classification: Electrolytes and minerals
Dosage: 1 tab tid x 6 doses
78
7/31/2019 CP Intestinal Obstruction Chap7
29/57
Mechanism of Action: Supplemental potassium in the form of high
potassium food or potassium chloride may be able to restore normal
potassium levels.
Indications:
For hypokalemia
As prophylaxis during treatment with diuretics
Indicated when potassium is depleted by severe vomiting, and
prolonged diuresis
Contraindications:
Severe renal impairment
Severe hemolytic reactions
Acute dehydration
Heat cramps
Hyperkalemia
Cautious use in: cardiac or renal disease; systematic acidosis
Adverse Reactions:
Renal insufficiency
Hyperkalemia
Nausea and Vomiting
Irritability and Muscle Weakness
Difficulty in swallowing
79
7/31/2019 CP Intestinal Obstruction Chap7
30/57
Nursing Responsibilities:
Some patients find it difficult to swallow the large sized KCl tablet.
Administer while patient is sitting up or standing (never in
recumbent position) to prevent drug- induced esophagus.
Dont crush sustained-release potassium products.
Monitor ECG and electrolyte levels during therapy.
Monitor for adverse effect that may reflect by perkalemia.
Health Teachings:
Tell patient to take with or after meals with full glass of water or fruit
juice to lessen GI distress.
Teach patient signs and symptoms of hyperkalemia, and tell patient
to notify prescriber if they occur.
Warn patient not to use salt substitutes concurrently, except with
prescribers permission.
Rationale: To provide a direct replacement of potassium in the body.
Drug # 3
Date Ordered: Dec. 09, 2010
Generic Name: domperidone
Brand Name: Motilium
Classification:Antidiarrheal and Antiemetic
Dosage: 10 mg 1 tab tid
80
7/31/2019 CP Intestinal Obstruction Chap7
31/57
Mechanism of Action: Gastrointestinal emptying (delayed) adjunct;
peristaltic stimulant: The gastroprokinetic properties of domperidone are
related to its peripheral dopamine receptor blocking properties. Motilium
facilitates gastric emptying and decreases small bowel transit time by
increasing esophageal and gastric peristalsis and by lowering esophageal
sphincter pressure. Antiemetic: The antiemetic properties of domperidone
are related to its dopamine receptor blocking activity at both the
chemoreceptor trigger zone and at the gastric level.
Indication: For management of dyspepsia, heartburn, epigastric pain,
nausea, and vomiting
Contraindications:
Known hypersensitivity to domperidone or any of the excipients
Prolactin-releasing pituitary tumour (prolactinoma).
Motilium should not be used when stimulation of the gastric motility
could be harmful:
Gastro-intestinal haemorrhage, mechanical obstruction or
perforation.
Adverse Reactions:
Immune System Disorder: Very rare; Allergic reaction
Endocrine disorder: Rare; increased prolactin levels
81
7/31/2019 CP Intestinal Obstruction Chap7
32/57
Nervous system disorders: Very rare; extrapyramidal side effects
Gastrointestinal disorders: Rare; gastro-intestinal disorders,
including very rare transient intestinal cramps
Skin and subcutaneous tissue disorders:Very rare; urticaria
Reproductive system and breast disorders: Rare; galactorrhoea,
gynaecomastia, amenorrhoea
Nursing Responsibilities:
If clinical symptoms dont improve within 48 hours, stop therapy and
consider other alternatives.
Drug produces antidiarrheal action similar to that of diphenoxylate
but without as many adverse CNS effects.
Know the patients sensitivity to domperidonebefore giving it.
Health Teachings:
Advise patient not to exceed recommended dosage.
Tell patient with acute diarrhea to stop drug and seek medical
attention if no improvement occurs within 48 hours. In chronic
diarrhea, tell patient to notify prescriber and to stop drug if no
improvement occurs after taking 16 mg daily for at least 10 days.
Advise patient with acute colitis to stop drug immediately and notify
prescriber about abdominal distention.
82
7/31/2019 CP Intestinal Obstruction Chap7
33/57
Warn patient to avoid activities that require mental alertness until
CNS effects of drug are known.
Rationale: To increase the movements or contractions of the stomach
and bowel. It is also used to treat nausea and vomiting.
Drug # 4
Date Ordered: Dec. 10, 2010
Generic Name: senna
83
7/31/2019 CP Intestinal Obstruction Chap7
34/57
Brand Name: Senokot Forte
Classification: Laxatives
Dosage: 2 tabs bid x3 doses
Mechanism of action: Unknown. Stimulant laxative that increases
peristalsis, probably by direct effect on smooth muscle of the intestine. Its
thought to either irritate the musculature or stimulate the colonic intramural
plexus. Drug also promotes fluid accumulation in colon and small
intestine.
Indication:Acute constipation, preparation for bowel examination.
Contraindications: Contraindicated in patients with ulcerative bowel
lesions, fecal impaction, intestinal obstruction, intestinal perforation, or
signs and symptoms of acute surgical abdomen, such as nausea,
vomiting, and abdominal pain.
Adverse reactions:
GI: nausea, vomiting, diarrhea, loss of normal bowel function with
excessive use, abdominal cramps, especially in severe
constipation, malabsorption of nutrients, yellow or yellow-green cast
to feces, darkened pigmentation of rectal mucosa with long-term
use, protein losing enteropathy.
GU: red-pink discoloration in alkaline urine, yellow-brown
discoloration in acidic urine.
Metabolic: electrolyte imbalance such as hypokalemia.
Other: laxative dependence with long-term or excessive use.
84
7/31/2019 CP Intestinal Obstruction Chap7
35/57
Nursing Responsibilities:
Before giving drug for constipation, determine whether patient has
adequate fluid intake, exercise and diet.
Limit diet to clear liquids after X-prep liquid is taken.
Avoid exposing product to excessive heat or light.
Drug is for short-term use.
Health Teachings:
Teach patient about dietary sources of bulk, including bran and
other cereals, fresh fruit, and vegetables.
Tell patient to report persistent or severe reactions.
Rationale: To stimulate peristalsis and increase intestinal motility.
Drug # 5
Date Ordered: Dec. 12, 2010
Generic Name: lactulose
85
7/31/2019 CP Intestinal Obstruction Chap7
36/57
Brand Name: Duphalac
Classification: Laxatives
Dosage: 30 cc now
Mechanism of Action: Produces an osmotic effect in colon; resulting
distention promotes peristalsis. Also decreases ammonia, probably as a
result of bacterial degradation, which lowers the pH of colon contents.
Indication: Constipation
Contraindications: Contraindicated in patients on a low galactose diet
and in those with diabetes mellitus.
Adverse Reactions:
GI: abdominal cramps, belching, diarrhea, gaseous distention,
flatulence, nausea, vomiting.
Nursing Responsibilities:
To minimize sweet taste, dilute with water or fruit juice or give with
food.
Prepare enema by adding 200 g (300 ml) to 700 ml of water or
normal saline solution. The diluted solution is given as retention
enema for 30 to 60 minutes. Use a rectal balloon.
If enema isnt retained for at least 30 minutes, be prepared to
repeat dose.
Monitor sodium level for hypernatremia, especially when giving to
patients with hepatic encephalopathy.
86
7/31/2019 CP Intestinal Obstruction Chap7
37/57
Monitor mental status and potassium level when giving to patients
with hepatic encephalopathy.
Be prepared to replace fluid loss.
Health Teachings:
Show home care patient how to mix and use drug.
Inform patient about adverse reactions and tell him to notify
prescriber if reactions become bothersome or if diarrhea occurs.
Instruct patient not to take other laxatives during lactulose therapy.
Rationale: To increase water content in colon and enhances peristalsis
and for the breakdown of products in colon that lead to acidification of
colonic contents, softening of feces, and decreased ammonia absorption
from colon to systemic circulation.
Drug # 6
Date Ordered: Dec. 13, 2010
Generic Name: cefuroxime
87
7/31/2019 CP Intestinal Obstruction Chap7
38/57
Brand Name: Zegen
Classification: Antibiotic
Cephalosporin ( 2nd generation)
Dosage: 750 mg q8 IVTT
Mechanism of Action: Cefuroxime is a bactericidal antibiotic, which
exerts antibacterial activity by inhibition of bacterial cell wall synthesis in
susceptible species. Cefuroxime has good stability to several bacterial
beta-lactamase enzymes and, consequently, is active against many
penicillin-resistant and amoxicillin-resistant strains of susceptible species.
Indications:
Lower respiratory tract infections caused by S. pneumoniae, S.
aureus, E. coli, Klebsiella, H. influenzae, S. pyogenes
Dermatologic infections caused by S. aureus, S. pyogenes, E. coli,
Klebsiella, Enterobacter
UTIs caused by E. coli, Klebsiella
Uncomplicated and disseminated gonorrhea caused by N.
gonorrhoea
Septicemia caused by S. pneumoniae, S. aureus, E. coli, Klebsiella,
H. influenzae
Meningitis caused by S. pneumoniae, H. influenzae, S. aureus, N.
meningitidis
Bone and joint infections caused by S. aureus
Perioperative prophylaxis
88
7/31/2019 CP Intestinal Obstruction Chap7
39/57
Contraindications:
Allergy to cephalosporins or penicillins
Renal failure
Adverse Reactions:
CNS: Headache, dizziness, lethargy, paresthesias
GI: Nausea, vomiting, diarrhea, anorexia, abdominal pain,
flatulence, pseudomembranous colitis, liver toxicity
Hematologic: Bone marrow depression: decreased WBC,
decreased platelets, decreased Hct
GU: Nephrotoxicity
Hypersensitivity: Ranging from rash to fever to anaphylaxis, serum
sickness reaction
Local: Pain, abscess at injection site; phlebitis, inflammation at IV
site
Other: Superinfections, disulfiram-like reaction with alcohol
Nursing Responsibilities:
Assess for history of hepatic and renal impairment
Observe the 12 rights when administering the drug
Have vitamin K available in case hypoprothrombinemia occurs
89
7/31/2019 CP Intestinal Obstruction Chap7
40/57
Discontinue if hypersensitivity occurs
Observe for adverse reactions
Do not mix with aminoglycosides
Inject slowly over 3-5min
Health Teachings:
Avoid alcohol while taking this drug and 3 days after because
severe reactions often occurs
May experience side effects
Report diarrhea, difficulty in breathing, unusual tiredness or fatigue,
pain at injection site
Rationale: To treat the existing acute infection.
Drug # 7
Date Ordered: Dec. 13, 2010
Generic Name: metronidazole
90
7/31/2019 CP Intestinal Obstruction Chap7
41/57
Brand Name: Rosex
Classification: Amebicide; Antibacterial; Antibiotic; Antiprotozoal
Dosage: 500mg q8 IVF @ am
Mechanism of Action: Metronidazole exerts rapid bactericidal effects
against anaerobic bacteria. It inhibits DNA synthesis, causing cell death.
Indications:
Acute infection with susceptible anaerobic bacteria
Acute intestinal amebiasis
Amebic liver abscess
Trichomonias ( acute and partners of patients with acute infection)
Bacterial vaginosis
Preoperative, intraoperative, postoperative prophylaxis for patients
undergoing colorectal surgery
Prophylaxis for patients undergoing abdominal surgery
Contraindications:
Hypersensitivity to metronidazole
Used cautiously with CNS, hepatic diseases, candidiasis, blood
dyscrasias
Adverse Reactions:
91
7/31/2019 CP Intestinal Obstruction Chap7
42/57
CNS: Headache, dizziness, ataxia, vertigo, incoordination,
insomnia, seizures, peripheral neuropathy, fatigue
GI : unpleasant metallic taste, anorexia, nausea, vomiting, diarrhea,
GI upset, cramps
GU:dysuria, incontinence, darkening of the urine
Local: thrombophlebitis
Other: Superinfections , disulfiram-like reaction with alcohol
Nursing Responsibilities:
Assess for history of CNS or hepatic disease, candidiasis, blood
dyscrasias
Reduce dosage with hepatic disease
Observe the 12 rights when administering the drug
Discontinue if hypersensitivity occurs
Observe for adverse reactions
Do not refrigerate neutralized solution
Do not administer solution that has not been neutralized
Infuse over 1hr
Discontinue other solutions while running metronidazole
Protect medication from sunlight
Health Teachings:
Take full course of drug therapy
92
7/31/2019 CP Intestinal Obstruction Chap7
43/57
Avoid alcohol while taking this drug and 3 days after because
severe reactions often occurs
May experience side effects
Expect dark colored urine
Report severe GI upset, dizziness, unusual fatigue or weakness,
fever, chills
Rationale: To treat the existing acute infection.
Drug # 8
Date Ordered: Dec. 13, 2010
Generic Name: diclofenac sodium
Brand Name: Voltaren
93
7/31/2019 CP Intestinal Obstruction Chap7
44/57
Classification: Analgesic (non-opioid); Anti-inflammatory (NSAID);
Antipyretic
Dosage: 20cc/hr IV
Mechanism of Action: Inhibits prostaglandin synthetase to cause
antipyretic and anti-inflammatory effects; the exact mechanism of action is
not known.
Indications:
Acute or long-term treatment of mild to moderate pain
Rheumatoid arthritis
Osteoarthritis
Ankylating spondylitis
Contraindications:
Contraindicated in the presence of significant renal impairment, and
allergies to NSAIDs
Use caution in the presence of impaired hearing, allergies, hepatic,
cardiovascular, and GI conditions and in elderly patients
Adverse Reactions:
CNS: Headache, dizziness, somnolence, insomnia, fatigue,
tiredness, dizziness, tinnitus, ophthamologic effects
94
7/31/2019 CP Intestinal Obstruction Chap7
45/57
GI: Nausea, dyspepsia, GI pain, vomiting, constipation, flatulence,
diarrhea, GI bleed
Hematologic: Bleeding, platelet inhibition with higher doses
GU: Dysuria, renal impairment
Dermatologic: Rash, pruritus, sweating, dry mucous membranes,
stomatitis
Other: Peripheral edema, anaphylactoid reactions to fatal
anaphylactic shock
Nursing Responsibilities:
Assess for history of hepatic and renal impairment, CV and GI
conditions, impaired hearing
Observe the 12 rights when administering the drug
Administer drug with food
Institute emergency procedures if overdose occurs
Observe for adverse reactions
Monitor with use of anticoagulants ( increased risk of bleeding)
Health Teachings:
Take drug with food
95
7/31/2019 CP Intestinal Obstruction Chap7
46/57
Take only the prescribed dosage
May experience side effects
Report sore throat, fever, rash, itching, weight gain, swelling in
ankles or fingers, changes in vision, black, tarry stools
Rationale: This drug is given to alleviate the pain perceived and
experienced.
96
7/31/2019 CP Intestinal Obstruction Chap7
47/57
Drug # 9
Date Ordered: Dec. 13, 2010
Generic Name: omeprazole
Brand Name: Omepron
Classification: Antisecretory drug; Proton pump
inhibitor
Dosage: 40mg IVTT OD
Mechanism of Action: Gastric acid pump inhibitor: Suppresses gastric
acid secretion by specific inhibition of the hydrogen-potassium ATPase
enzyme system at the secretory surface of the gastric parietal cells; blocks
the spinal step of acid production
Indications:
Short-term treatment of active duodenal ulcer
Treatment of heartburn or symptoms of GERD
Short-term treatment of active benign gastric ulcer
GERD
Eradication of H. Pylori
Reduction of risk of upper GI bleeding in critically ill patients
Contraindications:
Hypersensitivity to omeprazole or its components
97
7/31/2019 CP Intestinal Obstruction Chap7
48/57
Adverse Reactions:
CNS: Headache, dizziness, asthenia, vertigo, insomnia, apathy,
anxiety, paresthesia, dream abnormalities
GI: Nausea, vomiting, constipation, diarrhea, abdominal pain, dry
mouth, tongue atrophy
Dermatologic: Rash, inflammation, urticaria, pruritus, alopecia, dry
skin
Respiratory : cough, epistaxis
Other: back pain, fever
Nursing Responsibilities:
Assess for hypersensitivity to omeprazole or its components
Observe the 12 rights when administering the drug
Administer with antacids if needed administer before meals
Observe for adverse reactions
Health Teachings:
Take drug before meals and take only the prescribed dosage
May experience side effects and report severe headache,
worsening of symptoms, fever, chills
Rationale: This is given to suppress the gastric secretion and thus,
reduce the pain perceived.
98
7/31/2019 CP Intestinal Obstruction Chap7
49/57
Drug # 10
Date Ordered: Dec. 13, 2010
Generic name: nalbuphine
Brand name: Nubain
Classification: Opioid agonist-antagonist
analgesic
Dosage: 5mg q6 x 12 doses IVTT
Mechanism of Action: Nalbuphine acts as an agonist at specific opioid
receptors in the CNS to produce analgesia and sedation. It inhibits the
ascending pain pathways, altering the perception of and response to pain
by binding to opiate receptors in the CNS but also acts to cause
hallucinations and is an antagonist at mu receptors.
Indications:
Relief to moderate to severe pain
Preoperative analgesia, as a supplement to surgical anesthesia
Prevention and treatment of intrathecal morphine-induced pruritus after
CS
Contraindications:
Hypersensitivity to nalbuphine, sulfites
99
7/31/2019 CP Intestinal Obstruction Chap7
50/57
Use cautiously with emotionally unstable patients or those with
history of opioid abuse, bronchial asthma, COPD, respiratory
depression, anoxia, increased ICP,acute MI
Adverse Reactions:
CNS: sedation, clamminess, sweating, headache, nervousness,
restlessness, depression, crying, confusion, faintness, unusual
dreams, hallucinations, dizziness, vertigo, floating feeling, feeling of
heaviness, numbness, tingling, flushing, warmth, blurred vision
GI: Nausea, vomiting, cramps, dyspepsia, bitter taste dry mouth
GU: urinary urgency
Respiratory : respiratory depression, dyspnea, asthma
Nursing Responsibilities:
Assess for hypersensitivity to nalbuphine, sulfites, emotional
instability or history of opioid abuse, bronchial asthma, COPD,
respiratory depression, anoxia, increased ICP, and MI
Observe the 12 rights when administering the drug
Taper dosage when discontinuing after prolonged use to avoid
withdrawal symptoms
Reassure patient about addiction liability
Discontinue if hypersensitivity occurs
Observe for adverse reactions
100
7/31/2019 CP Intestinal Obstruction Chap7
51/57
Health Teachings:
May experience side effects
Avoid performing tasks that require alertness
For loss of appetite, lying quietly and eating small frequent meals
may help
Report severe nausea, vomiting, palpitations, shortness of breath,
or difficulty in breathing
Rationale: It is given to alleviate the pain experienced by the patient.
H. Prognosis
101
7/31/2019 CP Intestinal Obstruction Chap7
52/57
Scoring:
102
Poor
(1)
Fair
(2)
Good
(3)Justification
Duration of
Illness
She has already a 1 year background of
intermittent pain on her abdomen and lately,
she is having difficulty and inability to defecate.The physician believes that symptoms develop
gradually in time.
Onset
She was not diagnosed immediately since she
doesnt have regular check-ups. It is not clear
when was obstruction started and how she
acquired the tumor causing obstruction and
such manifestations.
PrecipitatingFactors
It is fair since she practices healthy lifestyle by
eating fruits and vegetables. She doesnt have
any vices like smoking and drinking alcohol.However, the real factors arent clear of what
aids in developing obstruction caused by the
tumor.
Willingness
to
Compliance
of
Treatment
When she found out what her condition is, all
she desires is for her cure and recovery. She
gives her trust to the health care providers and
is willing to cooperate with every procedure
and follows what the physician is saying. She
is also complying with the medications
prescribed for her.
Age
She is at higher risk because age is a
predisposing factor that may lead in having
intestinal obstruction.
Environment
She wants a clean environment especially at
their house. With that, she does household
chores to maintain neat and organized
surroundings.
Family
Support
She is well loved and supported by her
husband, children, and grandchildren. She has
a close relationship among them.
Good Fair Poor
3- 2.7 2.5- 1.6 1- 1.5
7/31/2019 CP Intestinal Obstruction Chap7
53/57
The patients score is 2.14 which is a fair prognosis. The patient
wasnt diagnosed immediately since she already had a one year
background of abdominal pain. She only then decided to have her check-
up after having difficulty in defecating. She was admitted and the
physician advised her o undergo surgery.
I. Discharge Planning
When client is to be discharged from the hospital, nursing care is
still continued. With sufficient support at home, most client recover
gradually. During home visits, the clients physical status and progress
103
7/31/2019 CP Intestinal Obstruction Chap7
54/57
towards recovery is assessed. The clients understanding of therapeutic
regimen is also assessed, and previous teaching is reinforced.
Method
Instruct the significant others to take the following home medication
as ordered by the physician.
Explain to the significant others the drug names as well as the right
route and dosage.
Inform the significant others about the side effects that may occur
brought by the medication.
Encourage the significant others to comply and follow religiously the
right timing in taking the medication.
Confer with the patients family the need take precautions regarding
medication therapy, activity, and dietary restriction.
Discuss with the patients family ways to cope with stressful
situations in positive manner.
Instruct patients family to report for immediate occurrence of signs
and symptoms to a health care professional.
Reinforce and supplement patients family knowledge about
diagnosis, prognosis, and expected level of function.
Provide patients family with specific directions about when to call the
physician and what complications require prompt attention.
104
7/31/2019 CP Intestinal Obstruction Chap7
55/57
Peer support and psychological counseling may be helpful for some
families.
Exercise/ Environment
Once at home, patient may resume much of the normal activity short
of aggressive physical exercise.
Walk short distances everyday and gradually increase activity.
No lifting of a weight greater than 20 lbs (9kg) for 6 weeks. Exercise
should be started cautiously.
Encouraged to practice deep breathing exercise and range of motion
exercises up to the level of capability.
Explain the need for rest periods both before and after certain
activities.
Teach client the importance of stress management through
relaxation technique, and regular appropriate exercise.
Help improve patients self-concept by providing positive feedback,
emphasizing strengths and encouraging social interaction and
pursuit of interests.
Treatment
105
7/31/2019 CP Intestinal Obstruction Chap7
56/57
Explain to the significant others the need to continue drug therapy
Provide patients family with a list of medications, with information on
action, purpose and possible side effects.
Advise significant others to always comply with the medications. Call
the physician if there is a problem taking them.
If the result of biopsy showed malignancy of the tumor,
chemotherapy must be followed up.
Hygiene
Keep proper hygiene. Teach clients family the importance of hygiene
like daily oral care, bathing and changing clothes.
Proper Wound care must be observed.
Outpatient
Advise to visit or have her follow up check-up with her attending
physician.
Advise to call and notify the attending physician for any unusualities
that may occur
106
7/31/2019 CP Intestinal Obstruction Chap7
57/57
Routinely, follow up check up with patients within two weeks. If
there are staples that require removal, postoperative problems, or
wound issues, a follow-up appointment will be scheduled sooner.
Diet
Emphasize to the clients family the importance of proper nutrition, its
need for early recovery. This can aid in restoring body functioning.
Provide dietary instructions to help patients family identify and
eliminate foods that is needed by the patient.
Soft or low residue diet upon discharge; this should be continued at
home for approximately 2 weeks (this includes breads, cereals,
chicken, fish, and soup).
Avoid large quantities of raw fruits and vegetables.
After 2 weeks, gradually reintroduce regular diet.
Encourage to drink plenty of fluids.
Take nutrition supplements